Business news
- Novo Nordisk shares tumble after company warns of sales hit this year - The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.
- House Republicans move toward reopening U.S. government - The government partially shut down Saturday morning after Congress failed to pass a six-bill package to fully fund the government.
- Musk's xAI, SpaceX combo is the biggest merger of all time, valued at $1.25 trillion - The record-setting deal will be the largest merger of all time and is valued at $1.25 trillion
- Ray Dalio warns the world is ‘on the brink’ of a capital war - The billionaire Bridgewater founder also weighed in on investing in gold after the metal was gripped by a sharp sell-off.
- Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18 - Disney has named Josh D'Amaro, chairman of Disney Experiences, as its next CEO, succeeding Bob Iger and clinching a closely watched succession race at the Mouse House.
- Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial - The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy.
- Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook - The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
- Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms - Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic competition.
- Trump refuses to be outdone by Europe, signing his own U.S.-India trade deal - The U.S. deal comes after global trading partners have been signing trade pacts, leaving America looking ostracized and more isolated.
- PepsiCo earnings beat estimates as drinks sales pick up around the world - PepsiCo reported fourth-quarter earnings and revenue that topped Wall Street's estimates.